Editorial & Advertiser disclosure

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Top Stories

Posted By Uma Rajagopal

Posted on October 29, 2024

Straumann’s sales rise, boosted by strong demand in Asia-Pacific

(Reuters) -Swiss dental implants maker Straumann on Tuesday reported a double-digit percentage rise in its organic revenue for the third quarter, as more people sought dental services around the world, especially in the Asia-Pacific region.

Revenue grew to 585.5 million Swiss Francs ($676.6 million) in the quarter, up 11.2% when excluding currency exchange effects and acquisitions.

The Asia-Pacific market, which makes up around a quarter of Straumann’s sales, recorded the highest year-on-year increase with 19.7% organic growth, mainly driven by the implantology business.

The region registered double-digit growth also excluding the fast-growing Chinese market, thanks to contributions from markets such as Thailand, India and Malaysia.

Revenue from Europe, Middle East and Africa (EMEA), the group’s biggest market generating 37% of sales, rose 11.4%. North America recorded 2% growth as it continued to suffer from slow patient flows and a soft implantology market, bringing in 27.8% of group sales, Straumann said.

“Our commitment to our customers and the dedication of our teams have once again helped us grow strongly,” CEO Guillaume Daniellot said in the earnings statement.

Straumann confirmed its full-year guidance for organic revenue growth in a low double-digit percentage range and profitability at 27-28% of sales based on constant 2023 currency rates.

($1 = 0.8653 Swiss francs)

(Reporting by Alberto Chiumento in Gdansk; editing by Milla Nissi)

Recommended for you

  • Enhancing Retail Banking Services Through Sentiment Analysis of Customer Feedback

  • Analyzing Mobile Banking Usage Patterns to Enhance Retail Customer Experience and Engagement

  • Industry 4.0 and Digital Transformation: Enhancing Operational Efficiency in Manufacturing